Skip to content

Helicobacter pylori drug sensitivity test kit (diffusion method) and Helicobacter pylori culture, determination, drug sensitivity test kit (microbial test method) for detection of Helicobacter pylori for different antibiotic sensitivity verification of equivalence

Helicobacter pylori drug sensitivity test kit (diffusion method) and Helicobacter pylori culture, determination, drug sensitivity test kit (microbial test method) for detection of Helicobacter pylori for different antibiotic sensitivity verification of equivalence

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043951
Enrollment
Unknown
Registered
2021-03-06
Start date
2021-03-03
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection

Interventions

Gold Standard:Helicobacter pylori culture was positive
Index test:Helicobacter&#32
was&#32

Sponsors

Shenzhen People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. The subject voluntarily signs the informed consent; 2, Aged 18-65 years, gender is not limited; 3. Patients who undergo gastroscopy and need gastric mucosal tissue for biopsy during gastroscopy; 4. Patients with positive results of Helicobacter pylori isolated and cultured from gastric mucosa tissue samples.

Exclusion criteria

Exclusion criteria: 1. Those who took oral antibiotics, bismuth agent or proton pump inhibitor within one month before the gastric mucosa tissue was taken by gastroscopy; 2. Patients who underwent gastroscopy but did not receive gastric mucosal biopsy; 3. Negative results of Helicobacter pylori separation and culture from gastric mucosa tissue samples; 4. Other researchers considered that the clinical conditions of gastric mucosal sampling by gastroscopy were not suitable.

Design outcomes

Primary

MeasureTime frame
Kappa;

Countries

China

Contacts

Public ContactFu-Rong Li
fuli62@163.com+86 755-22942145

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026